11Oct/13

Gainers Buzz: Gilead Sciences, Inc. (NASDAQ:GILD), Cemex SAB de CV (ADR … – Market News Call

Gainers Buzz: Gilead Sciences, Inc. (NASDAQ:GILD), Cemex SAB de CV (ADR
Market News Call
It demonstrated “highly statistically significant efficacy” in patients receiving the treatment receiving idelalisib plus rituximab compared with those receiving rituximab alone, the company said. Should Investors Buy GILD After Yesterday’s Slump? Find

11Oct/13

Genetically Modified Foods and PR Wars: Fighting Against Biotech Giants – Center for Research on Globalization

Genetically Modified Foods and PR Wars: Fighting Against Biotech Giants
Center for Research on Globalization
Last month, a new study published in the Journal of Food and Chemical Toxicology found that rats fed Monsanto’s patented NK603 gmo corn were more likely to develop tumours and suffer severe liver and kidney damage. The study followed 200 rats over two